SCOPUS 정보 검색 플랫폼

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 2, 2002, Pages 530-539

An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations

(7) Kamischke, Axel a Heuermann, Tanja b Krüger, Kathrin b Von Eckardstein, Sigrid a Schellschmidt, Ilka a Rübig, Alexander b Nieschlag, Eberhard a

a INST OF REPRO MED OF THE UNIV (Germany)

b BAYER PHARMA AG (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DESOGESTREL; GONADOTROPIN; MALE CONTRACEPTIVE AGENT; NORETHISTERONE ENANTATE; TESTOSTERONE UNDECANOATE;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; HEMATOCRIT; HORMONAL CONTRACEPTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE STERILITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SEXUAL FUNCTION; SIDE EFFECT; SPERMATOGENESIS; SPERMATOZOON COUNT; WELLBEING;

NETA;

EID: 0036171527 PISSN: 0021972X EISSN: None Source Type: Journal
DOI: 10.1210/jcem.87.2.8218 Document Type: Article

Times cited : (120)

References (35)

1
- 0025066149
- Contraceptive efficacy of testosterone-induced azoospermia in normal men
- (1990) Lancet , vol.336 , pp. 955-959

2
- 0029960780
- Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men
- (1996) Fertil Steril , vol.65 , pp. 821-829

3
- 0002526482
- Male contribution to contraception
- Nieschlag E, Behre HM, eds. Heidelberg: Springer
- (2000) Andrology: male reproductive health and dysfunction , pp. 399-418
- Nieschlag, E.¹ Behre, H.M.² Engelmann, U.³ Schwarzer, U.⁴

4
- 0002638719
- Hormonal male contraception: Suppression of spermatogenesis with GnRH antagonists and testosterone
- Filicori M, Flamigni C, eds. New York, London: Parthenon
- (1995) Treatment with GnRH analogs: controversies and perspectives , pp. 243-248
- Nieschlag, E.¹ Behre, H.M.²

5
- 2642647058
- Low dose of cyproterone acetate and testosterone enanthate for contraception in men
- (1998) Hum Reprod , vol.13 , pp. 1225-1229
- Meriggiola, M.C.¹ Bremner, W.J.² Costantino, A.³ Di Cintio, G.⁴ Flamigni, C.⁵

6
- 0032902148
- Oral progestogen combined with testosterone as a potential male contraceptive: Additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism
- (1999) J Clin Endocrinol Metab , vol.84 , pp. 112-122
- Wu, F.C.¹ Balasubramanian, R.² Mulders, T.M.³ Coelingh-Bennink, H.J.⁴

7
- 0035143149
- Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception
- (2001) J Clin Endocrinol Metab , vol.86 , pp. 303-309
- Kamischke, A.¹ Venherm, S.² Plöger, D.³ Von Eckardstein, S.⁴ Nieschlag, E.⁵

8
- 0035178738
- Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride
- (2001) J Androl , vol.22 , pp. 88-95
- Kinniburgh, D.¹ Anderson, R.A.² Baird, D.T.³

9
- 0033842110
- Intramuscular testosterone undecanoate with or without oral levonorgestrel: A randomized placebo-controlled feasibility study for male contraception
- Erratum published in Clin Endocrinol 53:661
- (2000) Clin Endocrinol (Oxf) , vol.53 , pp. 43-52
- Kamischke, A.¹ Plöger, D.² Venherm, S.³ Von Eckardstein, S.⁴ Von Eckardstein, A.⁵ Nieschlag, E.⁶

10
- 0033383771
- Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men
- (1999) Clin Endocrinol (Oxf) , vol.51 , pp. 757-763
- Nieschlag, E.¹ Büchter, D.² Von Eckardstein, S.³ Abshagen, K.⁴ Simoni, M.⁵ Behre, H.M.⁶

11
- 0032422573
- A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men
- (1998) J Androl , vol.19 , pp. 761-768
- Zhang, G.Y.¹ Gu, Y.Q.² Wang, X.H.³ Cui, Y.G.⁴ Bremner, W.J.⁵

12
- 0033304546
- A clinical trial of injectable testosterone undecanoate as a potential male contraceptive in normal Chinese men
- (1999) J Clin Endocrinol Metab , vol.84 , pp. 3642-3647
- Zhang, G.Y.¹ Gu, Y.Q.² Wang, X.H.³ Cui, Y.G.⁴ Bremner, W.J.⁵

13
- 0026497649
- Testosterone buciclate (20 Aet-1) in hypogonadal men: Pharmacokinetics and pharmacodynamics of the new long-acting androgen ester
- (1992) J Clin Endocrinol Metab , vol.75 , pp. 1204-1210
- Behre, H.M.¹ Nieschlag, E.²

14
- 0024419132
- Sustained inhibition of sperm production and inhibin secretion induced by a gonadotrophin-releasing hormone antagonist and delayed testosterone substitution in non-human primates (Macaca fascicularis)
- (1989) J Endocrinol , vol.123 , pp. 303-310
- Weinbauer, G.F.¹ Khurshid, S.² Fingscheidt, U.³ Nieschlag, E.⁴

15
- 0023935318
- Inhibition of spermatogenesis in men using various combinations of oral progestogens and percutaneous or oral androgens
- (1988) Int J Androl , vol.11 , pp. 187-199
- Guerin, J.F.¹ Rollet, J.²

16
- 0033305020
- A critical evaluation of simple methods for the estimation of free testosterone in serum
- (1999) J Clin Endocrinol Metab , vol.84 , pp. 3666-3672
- Vermeulen, A.¹ Verdonck, L.² Kaufman, J.M.³

17
- 0003567252
- Cambridge: Cambridge University Press
- (1999) WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 4th ed.

18
- 0026708871
- Internal quality control of semen analysis
- (1992) Fertil Steril , vol.58 , pp. 172-178
- Cooper, T.G.¹ Neuwinger, J.² Bahrs, S.³ Nieschlag, E.⁴

19
- 0033031511
- Experience with external quality control in spermatology
- (1999) Hum Reprod , vol.14 , pp. 765-769
- Cooper, T.G.¹ Atkinson, A.D.² Nieschlag, E.³

20
- 0026608161
- Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception
- (1992) J Clin Endocrinol Metab , vol.74 , pp. 84-90
- Behre, H.M.¹ Nashan, D.² Hubert, W.³ Nieschlag, E.⁴

21
- 0002604486
- Diagnosis of male infertility and hypogonadism
- Nieschlag E, Behre HM, eds. Heidelberg: Springer
- (2000) Andrology: male reproductive health and dysfunction , pp. 90-124
- Behre, H.M.¹ Yeung, C.H.² Holstein, A.F.³ Weinbauer, G.F.⁴ Gassner, P.⁵ Nieschlag, E.⁶

22
- 0034011741
- Potential impact of hormonal male contraception: Cross-cultural implications for development of novel preparations
- (2000) Hum Reprod , vol.15 , pp. 637-645
- Martin, C.W.¹ Anderson, R.A.² Cheng, L.³ Ho, P.C.⁴ Van der Spuy, Z.⁵ Smith, K.B.⁶ Glasier, A.F.⁷ Everington, D.⁸ Baird, D.T.⁹

23
- 0018240518
- Clinical trial with testosterone undecanoate for male fertility control
- (1978) Contraception , vol.18 , pp. 607-614
- Nieschlag, E.¹ Hoogen, H.² Bölk, M.³ Schuster, H.⁴ Wickings, E.J.⁵

24
- 0033323816
- Clinical trial of transdermal testosterone and oral levonorgestrel for male contraception
- (1999) J Clin Endocrinol Metab , vol.84 , pp. 1244-1249
- Büchter, D.¹ Von Eckardstein, S.² Von Eckardstein, A.³ Kamischke, A.⁴ Simoni, M.⁵ Behre, H.M.⁶ Nieschlag, E.⁷

25
- 0342460485
- An oral regimen of cyproterone acetate and testosterone undecanoate for spermatogenic suppression in men
- (1997) Fertil Steril , vol.68 , pp. 844-850
- Meriggiola, M.C.¹ Bremner, W.J.² Costantino, A.³ Pavani, A.⁴ Capelli, M.⁵ Flamigni, C.⁶

26
- 0025751705
- Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido
- (1991) J Clin Endocrinol Metab , vol.73 , pp. 1360-1369
- Pavlou, S.N.¹ Brewer, K.² Farley, M.G.³ Lindner, J.⁴ Bastias, M.C.⁵ Rogers, B.J.⁶ Swift, L.L.⁷ Rivier, J.E.⁸ Vale, W.W.⁹ Conn, P.M.¹⁰ Herbert, C.M.¹¹

27
- 0026688067
- Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate
- (1992) J Clin Endocrinol Metab , vol.75 , pp. 476-483
- Tom, L.¹ Bhasin, S.² Salameh, W.³ Steiner, B.⁴ Peterson, M.⁵ Sokol, R.Z.⁶ Rivier, J.⁷ Vale, W.⁸ Swerdloff, R.S.⁹

28
- 0031741889
- Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone
- (1998) J Clin Endocrinol Metab , vol.83 , pp. 3527-3533
- Swerdloff, R.S.¹ Bagatell, C.J.² Wang, C.³ Anawalt, B.D.⁴ Berman, N.⁵ Steiner, B.⁶ Bremner, W.J.⁷

29
- 0027250374
- Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens
- (1993) J Clin Endocrinol Metab , vol.77 , pp. 427-432
- Bagatell, C.J.¹ Matsumoto, A.M.² Christensen, R.B.³ Rivier, J.E.⁴ Bremner, W.J.⁵

30
- 0029811817
- A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive
- (1996) J Clin Endocrinol Metab , vol.81 , pp. 3018-3023
- Meriggiola, M.C.¹ Bremner, W.J.² Paulsen, C.A.³ Valdiserri, A.⁴ Incorvaia, L.⁵ Motta, R.⁶ Pavani, A.⁷ Capelli, M.⁸ Flamigni, C.⁹

31
- 0018389670
- The effects of low doses of cyproterone acetate on some functions of the reproductive system in normal men
- (1979) Acta Endocrinol (Copenh) , vol.91 , pp. 545-552
- Fogh, M.¹ Corker, C.S.² Hunter, W.M.³ McLean, H.⁴ Philip, J.⁵ Schou, G.⁶ Skakkebaek, N.E.⁷

32
- 0033795352
- Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression
- (2000) Fertil Steril , vol.74 , pp. 707-714
- Anawalt, B.D.¹ Herbst, K.L.² Matsumoto, A.M.³ Mulders, T.M.⁴ Coelingh-Bennink, H.J.⁵ Bremner, W.J.⁶

33
- 2642666506
- Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men
- (1998) Eur J Endocrinol , vol.138 , pp. 51-58
- Leifke, E.¹ Korner, H.C.² Link, T.M.³ Behre, H.M.⁴ Peters, P.E.⁵ Nieschlag, E.⁶

34
- 0001055417
- Androgens, cardiovascular risk factors and atherosclerosis
- Nieschlag E, Behre HM, eds. Berlin, Heidelberg, New York: Springer
- (1998) Testosterone: action, deficiency, substitution. 2nd ed. , pp. 229-257
- Von Eckardstein, A.¹

35
- 0033771336
- Prolactin: Structure, function, and regulation of secretion
- (2000) Physiol Rev , vol.80 , pp. 1523-1631
- Freeman, M.E.¹ Kanyicska, B.² Lerant, A.³ Nagy, G.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.